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Recombinant human gamma interferon (r-IFN--y) in-
duces the synthesis and expression of HLA-DR antigen 
on cultured, normal, human keratinocytes depleted of 
Langerhans cells. After removal of r-IFN--y from the 
culture medium of keratinocytes that are expressing 
HLA-DR antigen, the cells continue to express this an-
tigen for at least 2 days. r-IFN--y induces, in a dose 
dependent fashion, the synthesis of several triton-solu-
ble proteins with the most prominent having an appar-
ent molecular weight of 53,000. 
Whereas normal keratinocytes do not express HLA-
DR antigen in vivo, they do express HLA-DR in a vari-
ety of skin diseases such as lichen planus, graft-versus-
host disease, and mycosis fungoides. We propose that an 
understanding of lymphocyte-keratinocyte interactions 
in vivo may be achieved by further studies of the mech-
anism of action of r-IFN--y on cultured keratinocytes 
and that the results may provide insight into the patho-
physiology leading to a number of common inflamma-
tory and neoplastic skin diseases. 
In a number of skin diseases including lichen planus (LP), 
graft-versus-host disease (GVHD), and mycosis fungoides, 
keratinocytes express HLA-DR antigen, a class II major his-
tocompatibil ity antigen not normally expressed by epidermal 
keratinocytes [ 1- 4). The role of DR antigen expression in these 
diseases is not clear, but it is likely that the expression of this 
antigen on keratinocytes may be related to the pathogenesis of 
at least some of these disorders. 
Recent evidence from our laboratory shows that incubation 
of keratinocytes with human recombinant gamma interferon 
(r-IFN--y) in vitro resu lts in synthesis and expression of HLA-
DR by these cells after 3- 4 days [5- 6] . This induction of DR 
expression is seen in both transformed and nontransformed 
keratinocytes [7,8). Thus, expression of HLA-DR by keratino-
cytes in situ may be the result of the production of significant 
quantities of gamma interferon (-y-IFN) by proliferating, acti-
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vated T lymphocytes in vivo. In vitro, the proliferation of both 
transformed and nontransformed keratinocytes is inhibited by 
r-IFN--y in a concentration dependent fashion [7,8). This in -
hibition of growth is maintained for at least 14 days after a 
short (30 min) pulse of r-IFN--y in squamous cell carcinoma 
cell (SCL-1) cultures [8]. 
In order to better understand the interaction(s) of r-IFN--y 
with keratinocytes, we have defined the time course of DR 
expression on normal cultured keratinocytes after a 4-day pulse 
of r -IFN--y. Furthermore, we have determined whether pro-
tein(s) other than DR also are induced by r-IFN--y in these 
cells. 
MATERIALS AND METHODS 
Antibodies 
A murine monoclonal antibody (L243, an IgG2a) directed against 
the HLA-DR antigen (Becton Dickinson Monoclonal Center, Inc. , 
Mountain View, California) was diluted 1:10 in 5% heat-inactivated 
fetal calf serum (FCS) in Dulbecco's phosphate buffe.red saline, plus 
0.02% sodium azide (5 % FCS-DPBS). Leu-1 (Becton Dickinson) was 
used as an isotype control. Fluorescein isothiocyanate conjugated 
(FITC) rabbit antimouse lgG (R/M-FITC) was obtained from Miles 
Laboratory, Elkhart, Indiana. 
Interferon 
Human r-IFN--y made in E. coli was generously supplied by Dr. G. 
Burton (Genentech, San Francisco, California). The titer of the r-IFN-
i' as determined by virus inhibition plaque assay was 5 X 107 reference 
Uni ts/ml (U/ml) and the specific activity was 107 U/mg. 
Preparation of Dispersed Skin Cells 
Single cell suspensions of normal skin were prepared from facial 
skin obtained at surgery [9). Trimmed skin was cut into 1 X 5 em strips 
and split-cut with a Castroviejo keratotome set at 0.1 mm. The resulting 
slices were treated for 25 min at 37"C with 0.3% trypsin plus 0.1 % 
EDTA in GNK (0.8% NaCl, 0.04% KCl, 0.1 % glucose, 0.084% NaHC03 , 
pH 7.3) . Dispersed cells were suspended in Dulbecco's Modified Eagles 
medium supplemented with 10% heat inactivated FCS, 50 llg/ml gen-
tamicin, and 2 mM L-glutamine, termed complete growth medium 
(CGM). Viabi lity, as determined by trypan blue exclusion immediately 
after trypsinization, was 90% or better. Two X 106 small, round viable 
keratinocytes were seeded on 3.5 em collagen-coated Petri dishes (Lux, 
Flow Lab.) in CGM [9). The cells were maintained in a humidified 
incubator with 5% C02/ 95% air at 37"C. For the experiment monitoring 
DR expression, the r-IFN--y was added at 48 h after cell seeding and 
the medium changed 4 days later. The cells were washed 2X with CGM 
and incubated in 2 ml of CGM without r-IFN--y. All time points 
indicated for harvesting of cultures for antibody labeling refers to t his 
time point as day 0. 
Antibody Labeling and Fluorescence-Activated Cell Sorter (FACS) 
Analysis 
The cultured cells were washed with Dulbecco's phosphate buffered 
saline (DPBS) and the monolayer then was trypsinized for 10 min 
using 0.3% t rypsin plus 1% EDTA and resuspended in CGM. The cells 
were washed once with 5% FCS-DPBS and aliquots of 5 x 105-106 
viable cells were stained for 25 min on ice with anti-HLA-DR mono-
clonal antibody L243 (1 llg in 50 Ill per 106 cells). Nonspecific and Fe 
receptor-mediated background staining was determined either by omit-
ting the first step antibody, anti-HLA-DR, or substituting an isotype 
control antibody, Leu-1, for the first step. The cells were t hen washed 
once with 5% FCS-DPBS and stained for 25 min with 50 Ill of a 1:150 
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dilution of R/M-FITC (Miles Laboratories, Elkhart, Indiana). The 
labeled cells were washed twice with 5% FCS-DPBS and fixed with 1% 
paraformaldehyde in phosphate buffered saline (PBS). The fluores-
cence per cell was determined with a fluorescence -activated cell sorter 
(FACS Ill; Becton-Dickinson) and a histogram showing the number of 
stained cells against the intensity of fluorescence was recorded. 
[ 15S]Methionine Labeling and One-Dimensional Polyacrylamide Gel 
ElectrophoresLs (PAGE) 
In order to determine whether r-IFN--y treated keratinocytes syn-
thesize new proteins, we seeded keratinocytes and 3 days later incu-
bated the cultures with and without 100 U/ml r-IFN--y for 48 h. During 
the last 18 h, the medium was changed to methionine-free medium 
containing 0.5% FCS and [35S]methionine was added (10 ~tCi/ml). The 
cells were trypsinized and the cell suspensions added to serum to stop 
trypsin activity. The cells were collected by centrifugation, washed once 
with PBS and resuspended in 90 J.L I PBS containing 10 J.Lg/ml DNasc 
I, 10 ~tg/ml RNase, 1 mM phenyl methane sulphonyl fluoride, 1 mM N-
methylmaleimide, 5 mM Mg2SO, and 10 ~tl 10% triton X-100 in PBS 
added with mixing. After centrifugation the supernatant was carefully 
removed as the triton soluble fraction . The pellet was re-extracted 
successively with 50 mM citrate buffer pH 2.65 (CASC fraction) in the 
cold and 2% sodium dodecyl sulfate (SDS), 2.5% 2-mercaptoethanol 
(2-ME) in Tris pH 6.8 (sample buffer) at 1oo·c for 10 min. Protein 
factions were brought to 2% SDS, 2.5% 2-ME, by addition, if necessary, 
of an equal volume of 2X sample buffer and boiled for 10 min. Lane 
loads were adjusted to the same total activity. 
One-dimensional polyacrylamide gel electrophoresis was carried out 
using the discontinuous system of Laemmli at a constant current of 
200 mA/cm2 unti l the tracking dye (bromophenol blue) reached the 
bottom of the gel [10]. Gels were fixed in 50% methanol 10% acetic 
acid water, soaked in EnHance, washed for 1 h in water, dried, juxta-
posed to Kodak X-Omat film and stored in the dark at -7o·c for 6- 72 
h depending on the radioactivity in the gel and then developed. 
RESULTS 
Time Course of the Maintenance of HLA-DR Expression on 
Keratinocytes after RemovaL of r-IFN--y from the CuLtures 
W e determined whether keratinocytes contin~ to express 
HLA-DR in the absence of r-IFN--y (Table I). Normal , human 
keratinocytes were incubated for 4 days with or without 300 U/ 
ml r -IFN--y. At the end of this incubation, the cultures were 
washed 2X with CGM and representative cultures were har-
vested (t = 0) . The remaining plates were reincubated in CGM 
without r-IFN --y for 2, 6, and 8 days. At these times, the cells 
were trypsinized, stained with anti-HLA-DR antibody plus R/ 
M -FITC and analysed with the FACS. After 2 days incubation 
without r-IFN --y approximately the same proportion of kerati-
nocytes continued to express DR antigen as at the time when 
r -IFN --y was removed from the cultures (Table 1). By day 6, 
the number of cells expressing DR a nd the mean fluorescence 
per cell had dec reased markedly. Thus, the proportion of cells 
TABLE I. Duration of HLA-DR expression by human keratinocytes 
after removal of r-IFN--y from the culture medium 
Days after removal 
of r-IFN --y• 
0 
2 
6 
8 
Expression of HLA-DR antigen on 
keratinocytesb 
Proportion of positive cells Mean 
(% total cells) tluorescence/cell' 
56 
49 
10 
9 
122 
80 
14 
15 
• Time in culture after removal of r-fFN- -y. 
b Cells were trypsinized from the culture plate, washed, stained with 
monoclonal anti -DR antibody plus R/M-FITC and analyzed with the 
FACS using a linear scale. The percentage of stained cells compared to 
the tota l number of cells was dete rmined as was the mean fluorescence 
per individual cell. The background stai ning (cells labeled with an 
isotype control (Leu-1) plus R/M -FITC) was subtracted, as was the 
value for control cells (not treated with r-IFN--y ~t any time), harvested 
the same day and stained with anti-HLA-DR antibody. 
• Expressed in arbitrary units. 
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FIG 1. One-dimensional SDS polyacrylamide gel of proteins from 
[35S]methionine-labeled cultured keratinocytes. The 6 lanes on the left 
contain triton soluble proteins, the 6 lanes on the right contain struc-
tural proteins. (The arrow points to lane #1). Lanes 1- 3 and 7- 9 contain 
replicate protein aliquots from r-IFN--y treated cultures, lanes 4- 6 and 
10-12 were run with proteins extracted from control cultures. The r -
IFN--y treated cultures demonstrate a heavily labeled band with an 
apparent molecular weight of 53,000 (-->). The control cultures do not 
show a band in this area. The electrophoretic pattern of the structural 
proteins (lanes 7- 12) shows no differences between r-IFN--y treated 
and control cultures. 
expressing HLA-DR declined from 56% at day 0 to 9% at day 
8 and the mean fluorescence per cell decreased from 122 units 
to 15 units over the same time interval. A similar time depend-
ent loss of DR expression after removal of r-IFN--y was seen in 
2 other, separate experiments. 
Gamma Interferon Induces a N ew Triton Soluble Protein in 
Keratinocytes 
The triton soluble fraction of r-IFN--y treated cells demon-
strated the presence of newly synthesized proteins (other than 
HLA-DR) not present in untreated cultures {Fig. 1). A major 
band on SDS-PAGE gels had an apparent molecular weight of 
about 53,000. Thus, r-IFN --y induces the synthesis of at least 
one nonstructural protein, other than HLA-DR antigen. No 
differences were seen in the molecular pattern of the structural 
proteins of r- IFN --y treated and control keratinocyte cultures 
(Fig 1). 
DISCUSSION 
Recombinant -y-IFN induces HLA-DR antigen on normal 
human keratinocytes in vitro and after removal of the lym-
phokine, the keratinocytes continue to express DR for at least 
2 days. By day 6, the proportion of DR-positive cells has 
decreased to near background levels. Loss of cell surface stain-
ing as reflected by mean fluorescence per cell may represent 
discontinued synthesis or shedding of HLA-DR or internali-
zation/degradation of the antigen. In another system, it has 
been shown that synthesis of alpha interferon induced HLA 
proteins decreased markedly 48 h after removing the interferon 
from the cultures [11] . Further studies aimed at the demon-
stration of synthesis of mRNA for r-IFN--y induced proteins in 
keratinocytes are currently in progress in our laboratory (J . N. 
Mansbridge, in preparation). Since DR expression persists on 
the cultured keratinocytes after removal of r-IFN--y, it may be 
possible to use these cells as stimulator cells for allogeneic 
lymphocytes in the keratinocyte-lymphocyte reaction (KLR), 
an assay for expression of functional HLA-DR antigen on the 
cell surface. Experiments are in progress to determine the 
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FIG 2. Schematic diagram of the human epidermis showing an 
"activated" Langerhans cell (darhly stippled) extending dendritic proc-
esses around neighboring keratinocytes. The keratinocytes and Lan-
gerhans cell produce IL-l which attracts T cells from the peripheral 
circulation. The T cells (e) in this infil trate synthesize gamma inter-
feron (IF) which leads to synthesis and expression of HLA-DR antigen 
on the keratinocytes (lightly stippled cells) in the immediate vicinity. 
response of allogeneic lymphocytes to DR expressing kerati-
nocytes in the KLR (B. J. Nickoloff eta!, in preparation). 
The r-IFN--y causes t he synthesis of new soluble proteins, 
other than DR which is identifiable on gels as 2 polypeptides 
with molecular weights of 28,000 and 34,000 (12]. Using two-
dimensional PAGE we are further defining the molecular pat-
terns of the induced proteins (J. N. Mansbridge, in prepara-
tion). One of these, the 53,000 dalton protein described in t his 
paper, is a major keratinocyte product representing about 8 % 
of e5S]methionine incorporation into tr iton-soluble protein or 
3% of total protein, at saturating concentrations of -y-interferon 
(J. N. Mansbridge, unpublished results). Its role in the keratin-
ocyte response to -y-interferon is not known, however it may 
play a role in the inhibition of keratinocyte growth or may 
serve as a s ignal for neighboring cells which, in turn, may lead 
to skin pathology in vivo. Previous investigations using fibro-
blasts have a lso demonstrated t he induction of new prote ins 
(13]. 
One of the skin diseases in which keratinocytes express HLA-
DR in sit u is LP (1]. This chron ic, papulosquamous disease 
can occur either as a response to drugs, grafting of foreign cell s 
e.g., in GVHD , or without a definable precipitating event [14] . 
Histologically, LP shows a heavy, dermal infiltrate of activated 
T ce lls, th ickened granular layer and destruction of basal cells 
[15,16]. The majority of t he T lymphocytes are of the helper 
subtype, but t he infiltrate a lso includes a small proportion of 
cytotoxic/suppressor cells . Langerhans cells are increased in 
the epidermis (16]. We propose that release of large quantities 
of 'Y-IFN by activated dermal T cells is the critical pathologic 
event which leads to keratinocyte expression of HLA-DR in 
this disease (Fig 2). In this view, Langerhans ce lls and/or 
keratinocytes meet foreign antigen (e.g., virus, drug, a llogeneic 
cells) and produce interleukin 1 (IL-l) (17,18]. This lymphok-
ine attracts circulating T ce lls to t he area and stimulates t hem 
to proliferate [19] . T cell s in the dermis in turn produce ')'-IFN 
wh ich diffuses into the epidermis causing keratinocyte expres-
sion of HLA-DR and decreased proliferation [20]. Moreover, 
we propose that DR in combination with a foreign antigen 
expressed on t he surface of these keratinocytes is recognized as 
"nonautologous" by the cytotoxic T cells present at the dermal-
epidermal junction [16]. Some of these cells may then attack 
the keratinocytes resulting in the appearance of the Civatte 
bodies characteristic of LP [15]. Destruction of the basal cell 
layer results in a wound healing response [21] which in turn 
causes the appearance of increased numbers of Langerhans 
cells (M. Reusch, in preparation) and more IL-l is produced. 
In this way, the process becomes self-perpetuating. 
If this view of the etiology of LP is correct, we would predict 
that inhibitors of -y-IFN production or blocking of -y- IFN action 
on the target cells (i.e., keratinocytes) would be therapeutically 
efficacious in LP. Similarly, a local inhibitor of IL-l production 
or a blocker of IL-1 receptors on T cells should a lso interrupt 
t he pathologic events leading to clinical expression of LP. 
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